FIELD: medicine; pharmacology; oncology. SUBSTANCE: proposed invention recommends to use Dr.Dorogov's antiseptic stimulator ACD-2 as new medicinal preparation exhibiting antitumoral activity. EFFECT: new approach in oncology. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ENDOGENIC PHARMACEUTICAL COMPOSITION PREPARED ON BASIS OF GOAL-SEEKING ACTIVATION OF HUMORAL MEDIATORS OF BRAIN CORTEX NERVE ENDING | 2003 |
|
RU2244928C2 |
AGENT FOR MALIGNANT TUMOR LOCAL TREATMENT | 1992 |
|
RU2083200C1 |
MEDICINAL PREPARATION POSSESSING ANTITUMOR ACTIVITY | 1988 |
|
RU2039560C1 |
4(5)-(3-NITRO-4-(3,3-DIMETHYLTRIAZENO-1)PHENYL)IMIDAZOLE POSSESSING ANTITUMOR ACTIVITY | 1982 |
|
SU1074091A1 |
AGENT SHOWING ANTITUMOR EFFECT | 2001 |
|
RU2185819C1 |
5,7-O-BIS-(DIETHYLAMINOETHYL)-USNINIC ACID DITARTRATE SHOWING ANTITUMOR ACTIVITY | 1991 |
|
RU1782009C |
MAGNETICALLY CONTROLLED CARRIER, METHOD OF MANUFACTURING THEREOF, METHOD FOR PREPARING SUSPENSION OF MAGNETICALLY CONTROLLED DRUG, TREATMENT METHOD, ANTITUMOR, ANTIMETASTATIC, CHEMOTHERAPEUTIC, RADIATION, HEMO- AND IMMUNOSTIMULATING AGENT | 1997 |
|
RU2143266C1 |
DIHYDROCHLORIDE 1-(3-NITRO-4- METHOXYBENZENE)-2- [BIS-(2- CHLORETHYL) AMINOMETHYL]IMIDAZOLE POSSESSING ANTITUMOR ACTIVITY | 1981 |
|
SU976654A1 |
SUCROSE AND CARATAVIC ACID MONOESTER SHOWING ANTIMALIGNANT ACTIVITY | 1987 |
|
SU1515652A1 |
ANTIMETASTATIC DRUG | 1993 |
|
RU2023446C1 |
Authors
Dates
1997-12-20—Published
1994-05-23—Filed